NCT02515357

Brief Summary

Obstructive sleep apnea (OSA) is a sleep disorder characterized by recurrent episodes of partial or complete collapse of the upper airway during sleep, leading to pauses of breathing and arousals. Although previously considered as a local abnormality of the respiratory track, it is nowadays recognized as a systemic disease and an important cause of morbidity and mortality, since it is strongly associated with obesity (especially abdominal obesity) and cardiometabolic diseases, including cardiovascular diseases and diabetes mellitus. Interestingly, recent hypotheses support that the metabolic syndrome pathology, including insulin resistance, inflammation and oxidative stress may be involved in OSA pathogenesis. The modification of lifestyle habits, e.g. in terms of diet and physical activity, is currently explored as a mean of managing the disease in combination with the first line treatment, i.e., the application of continuous positive airway pressure (CPAP) during sleep. The available data support that weight loss, achieved through lifestyle modification, effectively reduces the severity of OSA and improves the associated cardiometabolic disorders in overweight or obese patients. However, studies exploring the potential effect of diet's quality or other lifestyle habits (such as physical activity) on OSA severity, besides weight loss, are currently lacking. Given that a Mediterranean dietary pattern, as well as other lifestyle habits adopted by the populations in the Mediterranean region, have been proven beneficial both for the prevention and the resolution of the metabolic syndrome and its associated cardiometabolic diseases, the aim of the present randomized, controlled, single-blind study is to implement an intensive intervention based on the Mediterranean lifestyle (hypocaloric diet and 7 group lifestyle counselling sessions) and to evaluate its potential benefits, compared with standard care (hypocaloric diet and written advice for healthy lifestyle), in a sample of patients with OSA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 4, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

September 7, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2020

Completed
Last Updated

January 26, 2021

Status Verified

January 1, 2021

Enrollment Period

4.3 years

First QC Date

July 28, 2015

Last Update Submit

January 25, 2021

Conditions

Keywords

Sleep DisordersMetabolic SyndromeMediterranean DietMediterranean Lifestyle

Outcome Measures

Primary Outcomes (1)

  • Severity of obstructive sleep apnea

    Reduction in the Apnea Hypopnea Index (AHI)

    6 months

Secondary Outcomes (7)

  • Sleep quality

    6 months

  • Daytime sleepiness

    6 months

  • Physical and mental health

    6 months

  • Insulin resistance

    6 months

  • Subclinical inflammation

    6 months

  • +2 more secondary outcomes

Study Arms (3)

Control group

PLACEBO COMPARATOR

This arm will receive standard care, i.e. CPAP prescription and brief written healthy lifestyle advice.

Behavioral: Standard care

Mediterranean lifestyle group

EXPERIMENTAL

This arm will receive a hypocaloric diet and attend a comprehensive 6-month lifestyle intervention based on the Mediterranean lifestyle on top of standard care.

Behavioral: Mediterranean lifestyle

Mediterranean diet group

EXPERIMENTAL

This arm will receive a hypocaloric diet and attend a comprehensive 6-month dietary intervention based on the Mediterranean dietary pattern on top of standard care.

Behavioral: Mediterranean diet

Interventions

Comprehensive 6-month lifestyle intervention (7 60-min group counselling sessions) aiming at promoting adherence to the Mediterranean lifestyle (food and food group consumption according to the Mediterranean diet, beneficial culinary practices, seasonality and locality of foods consumed, socialization during meals, adequate rest during the day through night sleep and siesta nap, sleep hygiene recommendations and adoption of a physically active lifestyle) and at achieving a 5-10% weight loss.

Mediterranean lifestyle group
Standard careBEHAVIORAL

General written instructions regarding the adoption of a healthy lifestyle.

Control group

Comprehensive 6-month lifestyle intervention (7 60-min group counselling sessions) aiming at promoting adherence to the Mediterranean dietary pattern (food and food group consumption according to the Mediterranean diet, beneficial culinary practices and seasonality and locality of foods consumed) and at achieving a 5-10% weight loss.

Mediterranean diet group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of obstructive sleep apnea diagnosed through polysomnography
  • Presence of overweight or obesity (Body Mass Index \> 25 kg/m2)

You may not qualify if:

  • Presence of central sleep apnea
  • Presence of other causes of sleep disorders, such as narcolepsy, restless leg syndrome or chronic pain syndrome
  • Hospitalization during the last year due to acute or chronic respiratory disease or required use of supplemental oxygen
  • Presence of diabetes mellitus
  • Presence of cardiovascular disease
  • Presence of severe hypertension (blood pressure \> 160/95 mm Hg)
  • Presence of neoplasm
  • Presence of chronic inflammatory diseases
  • Presence of psychiatric disorders, such as major depression, schizophrenia or suicidal ideation
  • Pregnancy or breast feeding (for women)
  • Surgery during the last three months
  • Reception of antipsychotics, antidepressants or other sleep inducing drugs, systematic reception of steroids or hormone replacement therapy for women
  • Excessive alcohol consumption (\> 210 or \> 140 gr of alcohol per week for men and women, respectively)
  • Adherence to a hypocaloric diet for weight loss or changes in dietary habits during the last six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Harokopio University

Kallithea, Attica, 17671, Greece

Location

Related Publications (4)

  • Georgoulis M, Yiannakouris N, Kechribari I, Lamprou K, Perraki E, Vagiakis E, Kontogianni MD. Sustained improvements in the cardiometabolic profile of patients with obstructive sleep apnea after a weight-loss Mediterranean diet/lifestyle intervention: 12-month follow-up (6 months post-intervention) of the "MIMOSA" randomized clinical trial. Nutr Metab Cardiovasc Dis. 2023 May;33(5):1019-1028. doi: 10.1016/j.numecd.2023.02.010. Epub 2023 Feb 18.

  • Georgoulis M, Yiannakouris N, Kechribari I, Lamprou K, Perraki E, Vagiakis E, Kontogianni MD. Dose-response relationship between weight loss and improvements in obstructive sleep apnea severity after a diet/lifestyle interventions: secondary analyses of the "MIMOSA" randomized clinical trial. J Clin Sleep Med. 2022 May 1;18(5):1251-1261. doi: 10.5664/jcsm.9834.

  • Georgoulis M, Yiannakouris N, Tenta R, Fragopoulou E, Kechribari I, Lamprou K, Perraki E, Vagiakis E, Kontogianni MD. A weight-loss Mediterranean diet/lifestyle intervention ameliorates inflammation and oxidative stress in patients with obstructive sleep apnea: results of the "MIMOSA" randomized clinical trial. Eur J Nutr. 2021 Oct;60(7):3799-3810. doi: 10.1007/s00394-021-02552-w. Epub 2021 Apr 10.

  • Georgoulis M, Yiannakouris N, Kechribari I, Lamprou K, Perraki E, Vagiakis E, Kontogianni MD. The effectiveness of a weight-loss Mediterranean diet/lifestyle intervention in the management of obstructive sleep apnea: Results of the "MIMOSA" randomized clinical trial. Clin Nutr. 2021 Mar;40(3):850-859. doi: 10.1016/j.clnu.2020.08.037. Epub 2020 Sep 6.

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Wake DisordersMetabolic Syndrome

Interventions

Standard of CareDiet, Mediterranean

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Meropi D Kontogianni, PhD

    Harokopio University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Nutrition

Study Record Dates

First Submitted

July 28, 2015

First Posted

August 4, 2015

Study Start

September 7, 2015

Primary Completion

January 10, 2020

Study Completion

January 10, 2020

Last Updated

January 26, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Data will be available upon demand.

Locations